Target intelligence / Profile preview

Dolichyl-phosphate mannosyltransferase subunit 3 (DPM3)

Target
DPM3
Molecular classification
Enzyme, Regulatory subunit of the dolichol-phosphate mannose synthase complex[1][2][8]
01

Overview

Dolichyl-phosphate mannosyltransferase subunit 3 (DPM3) is a regulatory and stabilizer subunit of the dolichol-phosphate mannose (DPM) synthase complex, a critical multi-protein enzyme in the endoplasmic reticulum required for synthesis of dolichol-phosphate mannose, an essential glycosyl donor for N-glycosylation and the production of glycosylphosphatidylinositol (GPI) anchors. The DPM3 protein tethers the catalytic subunit (DPM1) to the endoplasmic reticulum membrane. Disruption of DPM3 function impairs glycoprotein biosynthesis, leading to congenital disorders of glycosylation and certain forms of muscular dystrophy[1][2][8].

Other names
Dolichyl-phosphate mannosyltransferase polypeptide 3Dolichyl-phosphate beta-D-mannosyltransferase subunit 3Dolichol-phosphate mannosyltransferase subunit 3Dolichol-phosphate mannose synthase subunit 3Mannose-P-dolichol synthase subunit 3DPM synthase subunit 3MPD synthase subunit 3MGC125904[2]
02

Mechanism of action

No approved or investigational drugs are described to act by targeting this molecule; mechanism relates to its biological enzymatic and stabilizer role

03

Biological functions

N-glycosylationStabilization of the dolichol-phosphate mannose synthase complexFacilitates proper surface expression of GPI-anchored proteins by supporting Dol-P-Man production[1][2][8]
04

Disease associations

Congenital disorders of glycosylation (specifically type 1O)[1][2]Muscular dystrophy-dystroglycanopathy, types B, 15 and C, 15[2]
05

Safety considerations

Mutations cause severe multisystem disorders, particularly congenital disorders of glycosylationPotential risk in disrupting essential glycosylation pathways[1][2]

Beyond the preview

Go deeper on Dolichyl-phosphate mannosyltransferase subunit 3 (DPM3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dolichyl-phosphate mannosyltransferase subunit 3 (DPM3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call